AGENDA

Welcome & Introductions
8:00 - 8:15 am CT

Sucharu (Chris) Prakash, MD 
Oncologist & Regional Medical Director
Texas Oncology - Paris

Integrating the Latest Evidence on Immune Checkpoint Inhibitors Into the Management of Advanced Non-Small Cell Lung Cancer
8:15 - 9:15 am CT | 1.0 CME/CE

Mark G. Kris, MD 
Professor of Medicine
Weill Cornell Medical College
Attending Physician, Thoracic Oncology Service
Memorial Sloan Kettering Cancer Center

Sucharu (Chris) Prakash, MD 
Oncologist & Regional Medical Director
Texas Oncology - Paris

Evolving Treatment Paradigms in HR-Positive, HER2-Negative Breast Cancer: Integrating the Latest Evidence Into Clinical Practice
9:15 - 10:15 am CT | 1.0 CME/CE

Harold J. Burstein, MD, PhD 
Professor of Medicine
Harvard Medical School
Medical Oncologist
Dana-Farber Cancer Institute

Sucharu (Chris) Prakash, MD 
Oncologist & Regional Medical Director
Texas Oncology - Paris

Break
10:15 - 10:30 am CT

Management of Urothelial Carcinoma: Strategies for Addressing Health Disparities and Promoting Equitable Care
10:30 - 11:30 am CT | 1.0 CME/CE

Matthew D. Galsky, MD 
Professor of Medicine, Icahn School of Medicine at Mount Sinai
Director, Genitourinary Medical Oncology
Tisch Cancer Institute

Sucharu (Chris) Prakash, MD 
Oncologist & Regional Medical Director
Texas Oncology - Paris

Mitigating Disparities in Prostate Cancer Care: Strategies to Promote Equitable Care Across the Continuum
11:30 am - 12:30 pm CT | 1.0 CME/CE

Matthew R. Smith, MD, PhD 
Professor of Medicine
Harvard Medical School
Director, Genitourinary Malignancies Program
Massachusetts General Cancer Center

Sucharu (Chris) Prakash, MD 
Oncologist & Regional Medical Director
Texas Oncology - Paris

Break
12:30 - 12:45 pm CT

Overcoming Barriers to Equitable Care in Hepatocellular Carcinoma: Integrating New Evidence Into Clinical Practice
12:45 - 1:45 pm CT | 1.0 CME/CE

Ghassan K. Abou-Alfa, MD, MBA 
Attending Physician
Memorial Sloan Kettering Cancer Center

Sucharu (Chris) Prakash, MD
Oncologist & Regional Medical Director
Texas Oncology - Paris

Updates in the Diagnosis and Management of CLL: Strategies for Addressing Disparities in Patient Care and Outcomes
1:45 - 2:45 pm CT | 1.0 CME/CE

Matthew S. Davids, MD, MMSc 
Associate Professor of Medicine
Harvard Medical School
Director of Clinical Research, Division of Lymphoma
Dana-Farber Cancer Institute

Sucharu (Chris) Prakash, MD 
Oncologist & Regional Medical Director
Texas Oncology - Paris